ANTI‐NEUTROPHIL CYTOPLASM ANTIBODIES (ANCA) IN A PATIENT WITH THE VASCULITIS OF MYELODYSPLASIA

J. Savige,C. Smith,L. Chang,J. Duggan
DOI: https://doi.org/10.1111/j.1365-2141.1991.tb04501.x
1991-08-01
British Journal of Haematology
Abstract:We have read with interest the report by Laporte et n/(l9YO) in which they describe the effect of folinic acid on the expansion of the peripheral blood stem cell (PBSC) pool during haematopoietic recovery after chemotherapy. We have collected PBSC from 34 adult patients with acute leukaemia following consolidation chemotherapy. However, it was possible to obtain > 1 x loi of granulocyte/macrophage progenitor cells (CFU-GM) per kg of body weight in only 1 3 / 34 ( 38.20/,) cases during a single course of leukaepheresis consisting of four collections. For the remaining 2 1 patients, in whom the dose of CFU-GM collected was not sufficient for valid haemopoietic reconstitution, another course of leukapheresis was required to obtain sufficient CFLJGM. In patients with acute lymphoblastic leukaemia (ALL). malignant lymphoma, and solid tumours. we have employed granulocyte colony-stimulating factor (G-CSF) and > 1 x 10' CFU-CM/kg were collected in 10/14 (71.4%) cases tested during a single course of leukapheresis. Thus, the use of GCSF is a promising strategy for patients with low yields of CFU-GM. However, in patients with acute myelogenous leukaemia (AMI,) the use of G-CSF is restricted. since AML blasts have receptors for G-CSF and may be stimulated by GCSF. The report by Laporte rt ( I / ( 1 Y90) suggested the use of folinic acid for the expansion of the PBSC pool and we evaluated the effect of folinic acid on two patients with AML. Each patient underwent two courses of leukapheresis: the first leukapheresis was performed without folinic acid and the second one with folinic acid during haemopoietic recovery from intensive chemotherapy for the consolidation of complete remission. The chemotherapy regimens used were the same for the two courses of consolidation chemotherapy. Folinic acid ( 5 0 mg/d) was intravenously administered on day 1 5 from initiation of consolidation chemotherapy and continued through the leukapheresis. The numbers of CFUGM collected at the first leukapheresis were 5.6 x lO'/kg and 5.6 x I04/kg in the two patients, respectively. At the second course of leukapheresis with folinic acid, the yields of CFU-CM were 2.1 x 104/kg and 2 .4 x I04/kg, respectively. The numbers of erythroid progenitor cells (BFU-E) at the first course of leukapheresis were 1 5.0 x 1 O+/kg and 18.4 x 1 04/ kg, respectively, while the numbers a t the second leukapheresis with folinic acid were 5.0 x lO'/kg and 6.3 x 10'/kg, respectively. These data indicate that folinic acid did not result in an increase of CFU-GM and BFU-E. though the yields of CFU-GM have been reported to diminish following successive courses of chemotherapy (Reiffers et a/. 1987) . Therefore the effect of folinic acid should be evaluated in patients who achieved complete remission. In the report by Laporte et a/ (1 990) the first course of leukapheresis was performed during a recovery phase from remission induction chemotherapy while the second one was done during a recovery from consolidation chemotherapy. Since chemotherapy-induced myelosuppression is more profound after remission induction than after consolidation, it is difficult to compare the yields of PBSC under these different situations.
What problem does this paper attempt to address?